113 related articles for article (PubMed ID: 30909319)
1. SLC1A5 glutamine transporter is a target of MYC and mediates reduced mTORC1 signaling and increased fatty acid oxidation in long-lived Myc hypomorphic mice.
Zhao X; Petrashen AP; Sanders JA; Peterson AL; Sedivy JM
Aging Cell; 2019 Jun; 18(3):e12947. PubMed ID: 30909319
[TBL] [Abstract][Full Text] [Related]
2. The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer.
Najumudeen AK; Ceteci F; Fey SK; Hamm G; Steven RT; Hall H; Nikula CJ; Dexter A; Murta T; Race AM; Sumpton D; Vlahov N; Gay DM; Knight JRP; Jackstadt R; Leach JDG; Ridgway RA; Johnson ER; Nixon C; Hedley A; Gilroy K; Clark W; Malla SB; Dunne PD; Rodriguez-Blanco G; Critchlow SE; Mrowinska A; Malviya G; Solovyev D; Brown G; Lewis DY; Mackay GM; Strathdee D; Tardito S; Gottlieb E; ; Takats Z; Barry ST; Goodwin RJA; Bunch J; Bushell M; Campbell AD; Sansom OJ
Nat Genet; 2021 Jan; 53(1):16-26. PubMed ID: 33414552
[TBL] [Abstract][Full Text] [Related]
3. CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer.
Liu Y; Wang F; Yan G; Tong Y; Guo W; Li S; Qian Y; Li Q; Shu Y; Zhang L; Zhang Y; Xia Q
Cancer Lett; 2024 Jul; 595():217006. PubMed ID: 38823763
[TBL] [Abstract][Full Text] [Related]
4. Germline hypomorphic CARD11 mutations in severe atopic disease.
Ma CA; Stinson JR; Zhang Y; Abbott JK; Weinreich MA; Hauk PJ; Reynolds PR; Lyons JJ; Nelson CG; Ruffo E; Dorjbal B; Glauzy S; Yamakawa N; Arjunaraja S; Voss K; Stoddard J; Niemela J; Zhang Y; Rosenzweig SD; McElwee JJ; DiMaggio T; Matthews HF; Jones N; Stone KD; Palma A; Oleastro M; Prieto E; Bernasconi AR; Dubra G; Danielian S; Zaiat J; Marti MA; Kim B; Cooper MA; Romberg N; Meffre E; Gelfand EW; Snow AL; Milner JD
Nat Genet; 2017 Aug; 49(8):1192-1201. PubMed ID: 28628108
[TBL] [Abstract][Full Text] [Related]
5. tRF-29-79 regulates lung adenocarcinoma progression through mediating glutamine transporter SLC1A5.
Shi Y; Pan Z; Feng Y; Zhou Q; Wang Q; Wang H; Dong G; Xia W; Jiang F
Carcinogenesis; 2024 Jun; 45(6):409-423. PubMed ID: 38366384
[TBL] [Abstract][Full Text] [Related]
6. Particulate matter facilitates amphiregulin-dependent lung cancer proliferation through glutamine metabolism.
Jiang YJ; Ho TL; Chao CC; He XY; Chen PC; Cheng FJ; Huang WC; Huang CL; Liu PI; Tang CH
Int J Biol Sci; 2024; 20(8):3126-3139. PubMed ID: 38904011
[TBL] [Abstract][Full Text] [Related]
7. Tubular CPT1A deletion minimally affects aging and chronic kidney injury.
Hammoud S; Ivanova A; Osaki Y; Funk S; Yang H; Viquez O; Delgado R; Lu D; Phillips Mignemi M; Tonello J; Colon S; Lantier L; Wasserman DH; Humphreys BD; Koenitzer J; Kern J; de Caestecker M; Finkel T; Fogo A; Messias N; Lodhi IJ; Gewin LS
JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38516886
[TBL] [Abstract][Full Text] [Related]
8. mTORC1 promotes cell growth via m
Cho S; Lee G; Pickering BF; Jang C; Park JH; He L; Mathur L; Kim SS; Jung S; Tang HW; Monette S; Rabinowitz JD; Perrimon N; Jaffrey SR; Blenis J
Mol Cell; 2021 May; 81(10):2064-2075.e8. PubMed ID: 33756105
[TBL] [Abstract][Full Text] [Related]
9. Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation.
Adhikary G; Shrestha S; Naselsky W; Newland JJ; Chen X; Xu W; Emadi A; Friedberg JS; Eckert RL
Mol Carcinog; 2023 Apr; 62(4):438-449. PubMed ID: 36562471
[TBL] [Abstract][Full Text] [Related]
10. Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression.
Wu JJ; Liu J; Chen EB; Wang JJ; Cao L; Narayan N; Fergusson MM; Rovira II; Allen M; Springer DA; Lago CU; Zhang S; DuBois W; Ward T; deCabo R; Gavrilova O; Mock B; Finkel T
Cell Rep; 2013 Sep; 4(5):913-20. PubMed ID: 23994476
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase D Mediates Glutamine-Induced mTORC1 Activation to Promote Porcine Intestinal Epithelial Cell Proliferation.
Zhu M; Lu EQ; Yan L; Liu G; Huang K; Xu E; Zhang YY; Li XG
J Nutr; 2024 Apr; 154(4):1119-1129. PubMed ID: 38365119
[TBL] [Abstract][Full Text] [Related]
12. The crosstalk between MYC and mTORC1 during osteoclastogenesis.
Bae S; Oh B; Tsai J; Park PSU; Greenblatt MB; Giannopoulou EG; Park-Min KH
Front Cell Dev Biol; 2022; 10():920683. PubMed ID: 36060812
[TBL] [Abstract][Full Text] [Related]
13. SOD1 Phosphorylation by mTORC1 Couples Nutrient Sensing and Redox Regulation.
Tsang CK; Chen M; Cheng X; Qi Y; Chen Y; Das I; Li X; Vallat B; Fu LW; Qian CN; Wang HY; White E; Burley SK; Zheng XFS
Mol Cell; 2018 May; 70(3):502-515.e8. PubMed ID: 29727620
[TBL] [Abstract][Full Text] [Related]
14. CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing.
Liu Z; Liu W; Wang W; Ma Y; Wang Y; Drum DL; Cai J; Blevins H; Lee E; Shah S; Fisher PB; Wang X; Fang X; Guo C; Wang XY
Proc Natl Acad Sci U S A; 2023 Sep; 120(39):e2302878120. PubMed ID: 37722058
[TBL] [Abstract][Full Text] [Related]
15. Nuclear VCP drives colorectal cancer progression by promoting fatty acid oxidation.
Huang Y; Wang F; Lin X; Li Q; Lu Y; Zhang J; Shen X; Tan J; Qin Z; Chen J; Chen X; Pan G; Wang X; Zeng Y; Yang S; Liu J; Xing F; Li K; Zhang H
Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2221653120. PubMed ID: 37788309
[TBL] [Abstract][Full Text] [Related]
16. MYC sensitises cells to apoptosis by driving energetic demand.
Edwards-Hicks J; Su H; Mangolini M; Yoneten KK; Wills J; Rodriguez-Blanco G; Young C; Cho K; Barker H; Muir M; Guerrieri AN; Li XF; White R; Manasterski P; Mandrou E; Wills K; Chen J; Abraham E; Sateri K; Qian BZ; Bankhead P; Arends M; Gammoh N; von Kriegsheim A; Patti GJ; Sims AH; Acosta JC; Brunton V; Kranc KR; Christophorou M; Pearce EL; Ringshausen I; Finch AJ
Nat Commun; 2022 Aug; 13(1):4674. PubMed ID: 35945217
[TBL] [Abstract][Full Text] [Related]
17. Glutamine addiction: a new therapeutic target in cancer.
Wise DR; Thompson CB
Trends Biochem Sci; 2010 Aug; 35(8):427-33. PubMed ID: 20570523
[TBL] [Abstract][Full Text] [Related]
18. Onco-Circuit Addiction and Onco-Nutrient mTORC1 Signaling Vulnerability in a Model of Aggressive T Cell Malignancy.
Wang X; Cornish AE; Do MH; Brunner JS; Hsu TW; Xu Z; Malik I; Edwards C; Capistrano KJ; Zhang X; Ginsberg MH; Finley LWS; Lim MS; Horwitz SM; Li MO
bioRxiv; 2024 Apr; ():. PubMed ID: 38617314
[TBL] [Abstract][Full Text] [Related]
19. Metabolic and Transcriptional Modules Independently Diversify Plasma Cell Lifespan and Function.
Lam WY; Jash A; Yao CH; D'Souza L; Wong R; Nunley RM; Meares GP; Patti GJ; Bhattacharya D
Cell Rep; 2018 Aug; 24(9):2479-2492.e6. PubMed ID: 30157439
[TBL] [Abstract][Full Text] [Related]
20. ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.
Zhang Z; Liu R; Shuai Y; Huang Y; Jin R; Wang X; Luo J
Br J Cancer; 2020 Jan; 122(1):82-93. PubMed ID: 31819178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
